Home/Filings/4/0000896262-21-000064
4//SEC Filing

Kemmerly David L 4

Accession 0000896262-21-000064

CIK 0000896262other

Filed

Apr 28, 8:00 PM ET

Accepted

Apr 29, 6:31 PM ET

Size

10.7 KB

Accession

0000896262-21-000064

Insider Transaction Report

Form 4
Period: 2021-04-27
Kemmerly David L
See Remarks
Transactions
  • Sale

    Common Stock

    2021-04-27$290.12/sh4,875$1,414,33518,667 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2021-04-273,1250 total
    Exercise: $27.35Exp: 2025-05-01Common Stock (3,125 underlying)
  • Exercise/Conversion

    Common Stock

    2021-04-27$27.35/sh+3,125$85,46923,542 total
Holdings
  • Common Stock

    (indirect: By 401(k))
    506
Footnotes (5)
  • [F1]The total amount of shares beneficially owned includes 271 shares held in an employee stock purchase plan account.
  • [F2]These sales were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.
  • [F3]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $290.00 to $290.92, inclusive. The reporting person undertakes to provide to Amedisys, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.
  • [F4]The information in this report is based on a plan statement dated as of March 31, 2021.
  • [F5]On May 1, 2015, the reporting person was granted an option to purchase 37,500 shares of common stock. The option vested based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2015, 2016, 2017 and 2018. The performance criteria for 2018 were met, resulting in vesting of the option as to 9,375 shares (the "2018 Tranche Options"), subject to additional time-based vesting as follows: one-third of the 2018 Tranche Options vested on May 1, 2019, and two-thirds of the 2018 Tranche Options vested on May 1, 2020. After the transaction being reported herein, the reporting person has exercised all of the 2018 Tranche Options.

Issuer

AMEDISYS INC

CIK 0000896262

Entity typeother

Related Parties

1
  • filerCIK 0001673554

Filing Metadata

Form type
4
Filed
Apr 28, 8:00 PM ET
Accepted
Apr 29, 6:31 PM ET
Size
10.7 KB